Aerootic Pharmaceuticals Private Limited
About Aerootic Pharmaceuticals Private Limited
Data last updated:
Aerootic Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 15 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC326034. Its GSTIN is 09AAQCA2321M1ZF (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammad Shams Tabrez Alam and Narendra Kumar Awasthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P – 133 Second Floor Nafees Road Batla House Jamia Nagar Okhla, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.24 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹91,138 (net margin 0.7%) and EBITDA of ₹1.33 Lakh (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 84% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aerootic Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressP – 133 Second Floor Nafees Road Batla House Jamia Nagar Okhla, New Delhi, Delhi, India – 110025
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Aerootic Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aerootic Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Aerootic Pharmaceuticals Private Limited, buy the company report.
Financials of Aerootic Pharmaceuticals Private Limited
FY 2025 filings availableAerootic Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 84% over three years, including 15% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹91,138 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aerootic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aerootic Pharmaceuticals Private Limited
Aerootic Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Shams Tabrez Alam | Director | 15 Nov 2017 | 8 Years 11 Months | Current |
| Narendra Kumar Awasthi | Director | 15 Nov 2017 | 8 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Aerootic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aerootic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aerootic Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCA2321M1ZF | Uttar Pradesh | Active | 21 Dec 2021 |
To see the full GST registrations and return filing status of Aerootic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aerootic Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Mohammad Shams Tabrez Alam was appointed as Director on 15 Nov 2017.
Frequently asked questions
Aerootic Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 15 November 2017 (9+ years old) and is registered under CIN U74999DL2017PTC326034.
Aerootic Pharmaceuticals has 2 current directors:
- Mohammad Shams Tabrez Alam - Director
- Narendra Kumar Awasthi - Director
The latest financial statements of Aerootic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Aerootic Pharmaceuticals is 09AAQCA2321M1ZF, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aerootic Pharmaceuticals is U74999DL2017PTC326034. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aerootic Pharmaceuticals was incorporated on 15 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Mohammad Shams Tabrez Alam was appointed as Director on 15 Nov 2017. Narendra Kumar Awasthi was appointed as Director on 15 Nov 2017.
The registered office of Aerootic Pharmaceuticals is at P – 133 Second Floor Nafees Road Batla House Jamia Nagar Okhla, New Delhi, Delhi, India – 110025.
Aerootic Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Aerootic Pharmaceuticals is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
